Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 10: 1509, 2019.
Article in English | MEDLINE | ID: mdl-31379808

ABSTRACT

The gut microbiome plays an important role in the immune system development, maintenance of normal health status, and in disease progression. In this study, we comparatively examined the fecal microbiomes of Amish (rural) and non-Amish (urban) infants and investigated how they could affect the mucosal immune maturation in germ-free piglets that were inoculated with the two types of infant fecal microbiota (IFM). Differences in microbiome diversity and structure were noted between the two types of fecal microbiotas. The fecal microbiota of the non-Amish (urban) infants had a greater relative abundance of Actinobacteria and Bacteroidetes phyla, while that of the Amish (rural) counterparts was dominated by Firmicutes. Amish infants had greater species richness compared with the non-Amish infants' microbiota. The fecal microbiotas of the Amish and the non-Amish infants were successfully transplanted into germ-free piglets, and the diversity and structure of the microbiota in the transplanted piglets remained similar at phylum level but not at the genus level. Principal coordinates analysis (PCoA) based on Weighted-UniFrac distance revealed distinct microbiota structure in the intestines of the transplanted piglets. Shotgun metagenomic analysis also revealed clear differences in functional diversity of fecal microbiome between Amish and non-Amish donors as well as microbiota transplanted piglets. Specific functional features were enriched in either of the microbiota transplanted piglet groups directly corresponding to the predominance of certain bacterial populations in their gut environment. Some of the colonized bacterial genera were correlated with the frequency of important lymphoid and myeloid immune cells in the ileal submucosa and mesenteric lymph nodes (MLN), both important for mucosal immune maturation. Overall, this study demonstrated that transplantation of diverse IFM into germ-free piglets largely recapitulates the differences in gut microbiota structure between rural (Amish) and urban (non-Amish) infants. Thus, fecal microbiota transplantation to germ-free piglets could be a useful large animal model system for elucidating the impact of gut microbiota on the mucosal immune system development. Future studies can focus on determining the additional advantages of the pig model over the rodent model.


Subject(s)
Feces/microbiology , Gastrointestinal Microbiome/immunology , Microbiota/immunology , Mucous Membrane/immunology , Mucous Membrane/microbiology , Amish , Animals , Fecal Microbiota Transplantation/methods , Firmicutes/immunology , Humans , Infant , Metagenome/immunology , Swine
2.
Int J Nanomedicine ; 13: 6699-6715, 2018.
Article in English | MEDLINE | ID: mdl-30425484

ABSTRACT

BACKGROUND: Influenza (flu) is a constant threat to humans and animals, and vaccination is one of the most effective ways to mitigate the disease. Due to incomplete protection induced by current flu vaccines, development of novel flu vaccine candidates is warranted to achieve greater efficacy against constantly evolving flu viruses. METHODS: In the present study, we used liposome nanoparticle (<200 nm diameter)-based subunit flu vaccine containing ten encapsulated highly conserved B and T cell epitope peptides to induce protective immune response against a zoonotic swine influenza A virus (SwIAV) H1N1 challenge infection in a pig model. Furthermore, we used monosodium urate (MSU) crystals as an adjuvant and co-administered the vaccine formulation as an intranasal mist to flu-free nursery pigs, twice at 3-week intervals. RESULTS: Liposome peptides flu vaccine delivered with MSU adjuvant improved the hemagglutination inhibition antibody titer and mucosal IgA response against the SwIAV challenge and also against two other highly genetically variant IAVs. Liposomal vaccines also enhanced the frequency of peptides and virus-specific T-helper/memory cells and IFN-γ response. The improved specific cellular and mucosal humoral immune responses in adjuvanted liposomal peptides flu vaccine partially protected pigs from flu-induced fever and pneumonic lesions, and reduced the nasal virus shedding and viral load in the lungs. CONCLUSION: Overall, our study shows great promise for using liposome and MSU adjuvant- based subunit flu vaccine through the intranasal route, and provides scope for future, pre-clinical investigations in a pig model for developing potent human intranasal subunit flu vaccines.


Subject(s)
Adjuvants, Immunologic/pharmacology , Immunity , Influenza Vaccines/immunology , Nanoparticles/chemistry , Orthomyxoviridae Infections/immunology , Peptides/immunology , Uric Acid/pharmacology , Adjuvants, Immunologic/administration & dosage , Administration, Intranasal , Amino Acid Sequence , Animals , Antibody Formation/drug effects , Body Temperature/drug effects , Cytokines/biosynthesis , Dogs , Immunity/drug effects , Immunity, Mucosal/drug effects , Immunologic Memory/drug effects , Influenza A Virus, H1N1 Subtype , Liposomes , Lung/pathology , Lung/virology , Madin Darby Canine Kidney Cells , Nanoparticles/ultrastructure , Orthomyxoviridae Infections/virology , Peptides/chemistry , Sus scrofa , Th1 Cells/drug effects , Th1 Cells/immunology , Vaccination , Viral Load/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...